July 11, 2020

Volume X, Number 193

July 10, 2020

Subscribe to Latest Legal News and Analysis

July 09, 2020

Subscribe to Latest Legal News and Analysis

July 08, 2020

Subscribe to Latest Legal News and Analysis

Health Care Policy Happenings - September 17-21, 2018

Here are some key health care policy headlines from the past week that you may have missed.

Congress

Legislation and Committee Activity

Bloomberg: Opioids Compromise Already in the Works in Congress – Congress is working on a compromise package of bills to fight the opioid crisis and hopes to finish voting on it in the next two weeks. The Senate and House began working on the compromise before the Senate passed its package  on Sept. 17, Sen. Lamar Alexander (R-TN) said. They aim to have the package ready by Sept. 21, he saidRead More

Senate Passes Final Defense, Labor-HHS-Education Appropriations Minibus Conference Report – On Tuesday, Senate Appropriations Committee Chairman, Richard Shelby (R-AL),  praised the Senate’s passage of the final conference agreement reached on H.R. 6157, the second of three Fiscal Year 2019 minibus appropriations packages, which includes funding bills for the Department of Defense and Labor, Health and Human Services, Education, and Related Agencies subcommittees.  The bill also contains a continuing resolution (CR) through December 7, 2018, for any appropriations bills not enacted before October 1, 2018.  Following passage in the House, which is expected to vote on the legislation next week, the package will be sent to the President’s desk for his signature. Read More

Bipartisan Bill to Prohibit “Gag Clauses” That Can Cause Consumers to Overpay for Prescriptions Passes Senate – On Monday, by a vote of 98-2, the Senate passed legislation authored by U.S. Senators Susan Collins (R-ME) and Claire McCaskill (D-MO) to remove barriers that can prevent patients from paying the lowest possible prices for their prescription drugs. Read More

Stat: Top Trump Health Official Calls on Congress to do More on Drug Pricing – On Thursday, A top U.S. health official called on lawmakers in Congress to do more to help bring down drug prices, saying that the Trump administration had “given them a lot of opportunities to step in here.” I think Congress can do more,” said Joe Grogan, associate director for health programs at the Office of Management and Budget. Read More

Administration

OMB

Bloomberg: Health Information Blocking Proposal Under Review – On Monday, a long-awaited proposal designed to free up the electronic exchange of health-care information is under review by the government. The White House Office of Management and Budget received a proposed rule from the Health and Human Services Office for the National Coordinator for Health Information Technology that would define and prohibit information blocking by health system IT networks. Read More

HHS

Using Telemedicine to Combat the Opioid Epidemic – Combatting the opioid crisis is a top priority for the Trump Administration and HHS. We are making progress. Just last week we released the 2017 National Survey on Drug Use and Health (NSDUH) data, which showed significantly more people received treatment for substance use disorder in 2017 than in 2016; this was especially true for those with heroin-related opioid use disorders.  Read More

Politico: White House Seeks Telemedicine Expansion Advice – This week, telemedicine industry groups descended on Washington for the behind-closed doors meeting, where they complained to officials from the White House, HHS and the Federal Trade Commission about policy barriers to widespread access; many of them advocated for completely eliminating originating site restrictions for reimbursement. Read More

CMS

Medicare and Medicaid Programs; Proposed Regulatory Provisions to Promote Program Efficiency, Transparency, and Burden Reduction – On Monday, The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule to revise the applicable conditions of participation (CoPs) for providers and conditions for coverage (CfCs) as a continuation of our efforts to reduce regulatory burden in accordance with the January 30, 2017 Executive Order “Reducing Regulation and Controlling Regulatory Costs” (Executive Order 13771).  Read More

Looking Ahead

The Senate and House are in session next week. Government fiscal year ends on Sunday, September 30.

On Tuesday, the Senate Health, Education, Labor and Pensions (HELP) Subcommittee on Primary Health and Retirement Security will hold a hearing on health care in rural America.  Read More

On Thursday, the House Energy and Commerce Subcommittee on Health will hold a hearing on reducing U.S. maternal mortality. Read More

On Thursday, the Senate Health, Education, Labor and Pensions (HELP) Committee will hold a hearing on Reducing Heal

© 2020 Foley & Lardner LLPNational Law Review, Volume VIII, Number 268

TRENDING LEGAL ANALYSIS


About this Author

Scott Klug, Folry Lardner Law Firm, Public Affairs Attorney
Director

Scott Klug is a public affairs director and co-chair of the Federal Public Affairs Practice at the national law firm of Foley & Lardner LLP. The former Congressman represents a broad array of Foley’s clients in Washington and several state capitals. He is also able to draw on 15 years of experience as an Emmy Award-winning television reporter to help clients craft proactive media strategies particularly when faced with crisis management challenges.

For eight years, Mr. Klug represented Madison, Wisconsin in the U.S. Congress, where he developed an expertise in health care,...

608-258-4762
Michael K. Crossen, Foley Lardner, healthcare lawyer
Partner

Michael K. Crossen is a partner and business lawyer with Foley & Lardner LLP, where his practice focuses on public affairs.

Mr. Crossen provides government relations representation to clients, including private equity firms and hedge funds, and portfolio companies of each. He works with members of the U.S. House of Representatives and the Senate to shape legislation and administrative action and has a Republican public affairs presence across the United States.

202 295 4440
Dennis A. Cardoza, public affairs director, Foley Lardner, law firm
Director, Public Affairs

Dennis A. Cardoza is a public affairs director, co-chair of the Federal Public Affairs Practice and chair of the California Public Affairs Practice of Foley & Lardner LLP. He advises a broad range of clients on legislative, regulatory, and public policy and advocacy matters, and has extensive policy experience with respect to water resource, banking, housing, infrastructure, energy, agriculture, education, foreign affairs, and health care issues.

202-295-4015
Jennifer F. Walsh, public affairs director, Foley law firm
Director, Public Affairs

Jennifer F. Walsh is a public affairs director with Foley & Lardner LLP. She has extensive experience in government affairs, including a lengthy career as a senior staffer in the U.S. Congress and the California Legislature, and as a vice president for Federal Government Affairs at a top 20 Fortune 500 health care company. Ms. Walsh has effectively advanced key issues before the United States Senate, House of Representatives and the Administration. She is a member of the firm’s Government & Public Policy Practice.

202-295-4762
Theodore H. Bornstein, Foley Lardner, Legislative Drafting Lawyer, Government Public Policy attorney
Partner

Theodore H. Bornstein is a partner and public policy lawyer with Foley & Lardner LLP and a member of the Government & Public Policy Practice. He serves as counsel to the firm’s Federal Public Affairs Practice, providing the practice and Foley’s clients with experienced legal and legislative drafting advice. He is also a member of the Automotive Industry Team. As Foley's most senior lobbyist, he oversees the federal lobbying practice in Foley's Washington, D.C. office and also works with an experienced Political Law team to advise clients on permissible political...

202-945-6188